“Pharmacy Benefit Mismanagers” and 340B Abuse: Oncology Leader Shares Key “Fights”
“We’ve been fighting the same fights for a long time,” says Miriam J. Atkins, MD, medical oncologist with the AO Multispecialty Clinic in Augusta, Georgia, and president of the Community Oncology Alliance (COA). Speaking at the COA 2024 Community Oncology Conference, Dr. Atkins discussed how the organization’s focus on reducing pharmacy benefit manager (PBM) involvement, as well as addressing 340B drug pricing abuse and vertical integration in oncology, is making a difference.
“We’ve been fighting the same fights for a long time,” says Miriam J. Atkins, MD, medical oncologist with the AO Multispecialty Clinic in Augusta, Georgia, and president of the Community Oncology Alliance (COA). Speaking at the COA 2024 Community Oncology Conference, Dr. Atkins discussed how the organization’s focus on reducing pharmacy benefit manager (PBM) involvement, as well as addressing 340B drug pricing abuse and vertical integration in oncology, is making a difference.
“Pharmacy Benefit Mismanagers” and 340B Abuse: Oncology Leader Shares Key “Fights”
“We’ve been fighting the same fights for a long time,” says Miriam J. Atkins, MD, medical oncologist with the AO Multispecialty Clinic in Augusta, Georgia, and president of the Community Oncology Alliance (COA). Speaking at the COA 2024 Community Oncology Conference, Dr. Atkins discussed how the organization’s focus on reducing pharmacy benefit manager (PBM) involvement, as well as addressing 340B drug pricing abuse and vertical integration in oncology, is making a difference.
“We’ve been fighting the same fights for a long time,” says Miriam J. Atkins, MD, medical oncologist with the AO Multispecialty Clinic in Augusta, Georgia, and president of the Community Oncology Alliance (COA). Speaking at the COA 2024 Community Oncology Conference, Dr. Atkins discussed how the organization’s focus on reducing pharmacy benefit manager (PBM) involvement, as well as addressing 340B drug pricing abuse and vertical integration in oncology, is making a difference.
